Patient Empowerment empowered patients can change healthcare outcomes and impact the pharmaceutical industry

Datamonitor has identified the key trends and events that drive patient empowerment and impact the pharmaceutical industry. These range from the increased access to information via internet and the rising pressures of cost containment through to how patient empowerment is affecting access to drugs as well as changing pharmaceutical marketing strategies and their public image.

Scope of this report

* Overview of the key trends driving patient empowerment

* Overview of how empowered patients and patient advocacy groups can change healthcare outcomes including case studies

* Analysis of the marketing strategies that companies are using to address the rise in patient education and harness patient power

* Identification of future trends shaping evolution of patient empowerment

Research and analysis highlights

Increased access to the internet, the rising pressures of cost containment and the changing patient-physician relationship are the key factors driving the rise in patient empowerment. Disease characteristics are one of the key factors determining how powerful different patient groups are.

Empowered patients can influence most healthcare outcomes: access to drugs, reimbursement policies, approval of new drugs, clinical trial recruitment, patient compliance and prescription rates. However they can also lead to reduction in drug prices and negative publicity for the pharmaceutical industry.

Pharmaceutical companies are investing effort into harnessing patient power through working with patient advocacy groups. Legal restrictions and increased public scrutiny are limiting how companies can work with patient groups and communication of medical information is the main form of contact in Europe.

Key reasons to read this report

* Identify the key trends that are driving a rise in patient empowerment

* Understand how patient advocacy groups can affect the pharmaceutical industry

* Gain insight into how pharmaceutical companies are working with patient advocacy groups and how marketing strategies are becoming more patient-focused

Published: 20 July 2007

PDF Format
Table of Contents
Price: $5,700.00 / GBP2,850.00